Ultra-low Dose Oral Ketamine for Chronic Pain in the Primary Care Setting
Status:
Unknown status
Trial end date:
2015-06-01
Target enrollment:
Participant gender:
Summary
This project is a pilot study to evaluate the analgesic and opioid-sparing effects of
ketamine in an ultra-low dose oral formulation as a novel intervention for treatment of
chronic non-cancer pain in opioid-tolerant patients in the primary care outpatient setting.